ClinConnect ClinConnect Logo
Search / Trial NCT06400628

Effectiveness of Chronic Self-management Education on Behavioral and Clinical Outcomes

Launched by JIMMA UNIVERSITY · May 2, 2024

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is investigating how effective self-management education can be for patients with rheumatic heart disease. The study aims to help patients manage their condition better, improve their health outcomes, and reduce feelings of depression and anxiety. Participants will receive monthly educational sessions over four months at Jimma Medical Center, where they will learn strategies to manage their health. The researchers will assess the patients’ health before and after these sessions to see how much they have improved.

To be eligible for this study, participants must be at least 15 years old and have been diagnosed with rheumatic heart disease for at least six months. They should be able to communicate effectively and understand the study's purpose. Those with serious medical conditions or specific chronic illnesses like diabetes or advanced cancer are excluded. If you decide to participate, you'll attend four educational sessions lasting between 30 to 45 minutes each, tailored to your needs. Your involvement could help improve your health and well-being while contributing to valuable research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Inclusion criteria
  • Patients aged 15 years and above with verified diagnosis through echocardiography imaging.
  • Patients diagnosed as rheumatic heart disease for at least 6 months by a cardiologist. New York Heart Association (NYHA) function Class II/III.
  • Participants who possess the ability to effectively communicate, comprehend the study objectives, and
  • Provided consent to participate in the research.
  • Exclusion Criteria:
  • Patients under serious medical conditions,
  • The existence of chronic illnesses like chronic obstructive pulmonary disease or asthma, diabetes, chronic kidney failure, stroke, or advanced-stage cancer.

About Jimma University

Jimma University is a leading academic institution in Ethiopia, renowned for its commitment to advancing health sciences and promoting research initiatives. As a clinical trial sponsor, Jimma University leverages its extensive expertise in public health and medicine to conduct rigorous and ethical research aimed at addressing critical health challenges in the region. The university collaborates with various stakeholders, including local and international research organizations, to enhance the quality and impact of its clinical studies. By fostering innovation and knowledge dissemination, Jimma University plays a pivotal role in improving health outcomes and contributing to the global body of medical knowledge.

Locations

Jimma, Oromi, Ethiopia

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported